Revance Therapeutics (RVNC) - Market capitalization

Market cap: €0.37 Billion

As of November 2024 Revance Therapeutics has a market cap of €0.37 Billion. This makes Revance Therapeutics the world's 7076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2024

End of year Market Cap

Year	Marketcap	Change
2024	€0.37 B	-46.47%
2023	€0.69 B	-50.68%
2022	€1.41 B	36.85%
2021	€1.03 B	-32.53%
2020	€1.53 B	102.07%
2019	€0.75 B	16.63%
2018	€0.65 B	-39.95%
2017	€1.08 B	93.06%
2016	€0.56 B	-36.5%
2015	€0.88 B	166.89%
2014	€0.33 B

End of Day market cap according to different sources

On Nov 22nd, 2024 the market cap of Revance Therapeutics was reported to be:

€0.37 Billion

by Nasdaq

€0.37 Billion

by CompaniesMarketCap

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
MediciNova MNOV	€99.78 M	-73.30%	🇺🇸 USA
Johnson & Johnson JNJ	€356.84 B	95,377.96%	🇺🇸 USA
Biogen BIIB	€21.97 B	5,780.38%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Market capitalization of Revance Therapeutics (RVNC)

Market cap: €0.37 Billion